Rob Barrow
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Rob Barrow
Rob Barrow is recorded as CEO at Definium Therapeutics, Inc. (DFTX). Rob Barrow has spoken on 9 earnings calls across 1 company, most recently for Definium Therapeutics, Inc. on February 26, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Definium Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Roger Crystal CEO
- Dr. Suzanne Bruhn CEO
- JR Rahn CEO
- Robert Barrow CEO
- Stephen Hurst CEO
- Carol A. Vallone Chairman
- Brandi L. Roberts CFO
- David Gryska CFO
- Roger Adsett COO, Board Member
- Carrie F. Liao Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.